Skip to main content
Clinical Trials/JPRN-jRCT1030220014
JPRN-jRCT1030220014
Recruiting
未知

A multi-institutional study on the assessment of sarcopenia and its relationship to ability in pediatric and AYA cancer survivors

Iwata Shintaro0 sites40 target enrollmentApril 8, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Iwata Shintaro
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 8, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Iwata Shintaro

Eligibility Criteria

Inclusion Criteria

  • 1\) All cancer patients scheduled for initial treatment at the study site.
  • 2\) Patients aged between 16 and 39 years at the time of consent.
  • 3\) Written consent has been obtained from the individual (if the research subject is a minor 16 years of age or older, written consent should be obtained from a surrogate in addition to the individual).

Exclusion Criteria

  • 1\) Patients who cannot be assessed for their ambulance status due to poor general condition.
  • 2\) Patients deemed inappropriate by the principal investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials